发明名称 GLYCINE TRANSPORTER INHIBITOR
摘要 The present invention provides novel compounds of formula [IA] or pharmaceutically acceptable salts thereof: which are useful in the prevention or treatment of diseases such as schizophrenia, Alzheimer's disease, cognitive impairment, dementia, anxiety disorders (e.g., generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, post-traumatic stress disorder, specific phobias, acute stress disorder), depression, drug dependence, spasm, tremor, pain, Parkinson's disease, attention deficit hyperactivity disorder, bipolar disorder, eating disorder, or sleep disorders, which is based on the glycine uptake-inhibiting action.
申请公布号 EP3009421(A1) 申请公布日期 2016.04.20
申请号 EP20140810255 申请日期 2014.06.09
申请人 TAISHO PHARMACEUTICAL CO., LTD. 发明人 YAMADA, YOUSUKE;OHTA, HIROSHI;TAMITA, TOMOKO;ABE, KUMI;YAMAMOTO, SHUJI;SHIROKAWA, SHIN-ICHI;ABE, MASAHITO;MATSUDA, YOHEI;ARAKI, YUKO
分类号 C07C233/73;A61K31/166;A61K31/277;A61K31/415;A61K31/44;A61K31/4439;A61K31/497;A61K31/505;A61K31/506;A61P1/00;A61P21/00;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P29/00 主分类号 C07C233/73
代理机构 代理人
主权项
地址